These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


546 related items for PubMed ID: 22616137

  • 1. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2012 May 18; 77(97):29665-6. PubMed ID: 22616137
    [Abstract] [Full Text] [Related]

  • 2. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2001 Jul 13; 66(135):36791-2. PubMed ID: 12356097
    [Abstract] [Full Text] [Related]

  • 3. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2010 Jan 21; 75(13):3471-2. PubMed ID: 20349552
    [Abstract] [Full Text] [Related]

  • 4. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2012 Jun 07; 77(110):33748-9. PubMed ID: 22675782
    [Abstract] [Full Text] [Related]

  • 5. International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Feb 05; 69(24):5551-2. PubMed ID: 14968802
    [Abstract] [Full Text] [Related]

  • 6. International Conference on Harmonisation; S10 Photosafety Evaluation of Pharmaceuticals; guidance for industry; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2015 Jan 27; 80(17):4282-3. PubMed ID: 25730921
    [Abstract] [Full Text] [Related]

  • 7. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2001 May 14; 66(93):24390-1. PubMed ID: 12356096
    [Abstract] [Full Text] [Related]

  • 8. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2001 Oct 16; 66(200):52634-7. PubMed ID: 12358037
    [Abstract] [Full Text] [Related]

  • 9. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2006 Jun 02; 71(106):32105-6. PubMed ID: 16795933
    [Abstract] [Full Text] [Related]

  • 10. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Apr 02; 68(63):16060-1. PubMed ID: 12674113
    [Abstract] [Full Text] [Related]

  • 11. International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2005 Apr 01; 70(62):16827-8. PubMed ID: 15803631
    [Abstract] [Full Text] [Related]

  • 12. International Conference on Harmonisation; Guidance on S9 Nonclincal Evaluation for Anticancer Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2010 Mar 08; 75(44):10487-8. PubMed ID: 20383918
    [Abstract] [Full Text] [Related]

  • 13. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2000 Dec 15; 65(242):78493-4. PubMed ID: 12362934
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2006 May 22; 71(98):29344-5. PubMed ID: 16749216
    [Abstract] [Full Text] [Related]

  • 20. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2009 Jan 09; 74(6):908-9. PubMed ID: 20333832
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.